Dr Migden is a distinguished US-based dermatologist and Professor, Departments of Dermatology, Division of Internal Medicine and Head and Neck Surgery, Division of Surgery at the University of Texas MD Anderson Cancer Center, Houston, TX, USA. At MD Anderson he is program director of the ACGME Fellowship:Micrographic Surgery and Dermatologic Oncology. He also serves as faculty for the Department of Ophthalmic Plastic & Reconstructive Surgery. He has served as a principal investigator for studies on the smoothened inhibitors sonidegib, vismodegib, and taladegib and.on immune therapy trials in non-melanoma skin cancer. Dr Migden has published numerous primary and expert review articles on basal cell carcinoma.